Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Saudi Arabia · Delayed Price · Currency is SAR 262.20
+2.00 (0.77%)
Jul 31, 2025, 3:19 PM AST
TADAWUL:4013 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 12,648 | 11,200 | 9,508 | 8,311 | 7,250 | 5,862 | Upgrade | |
Revenue Growth (YoY) | 26.17% | 17.79% | 14.41% | 14.62% | 23.69% | 16.85% | Upgrade |
Cost of Revenue | 8,579 | 7,471 | 6,255 | 5,578 | 4,934 | 4,009 | Upgrade |
Gross Profit | 4,069 | 3,730 | 3,254 | 2,733 | 2,316 | 1,853 | Upgrade |
Selling, General & Admin | 1,549 | 1,373 | 1,158 | 1,032 | 850.28 | 737.94 | Upgrade |
Operating Expenses | 1,549 | 1,373 | 1,158 | 1,032 | 850.28 | 737.94 | Upgrade |
Operating Income | 2,519 | 2,356 | 2,096 | 1,700 | 1,466 | 1,115 | Upgrade |
Interest Expense | -286.07 | -162.76 | -70.11 | -49.36 | -37.9 | -48.5 | Upgrade |
Interest & Investment Income | 56.76 | 56.76 | 82.13 | 40.72 | 9.9 | 13.05 | Upgrade |
Earnings From Equity Investments | 19.27 | 20.99 | 22.18 | 19.61 | 7.49 | 1.84 | Upgrade |
Other Non Operating Income (Expenses) | 104.38 | 97.93 | 40.14 | 85.2 | 55.7 | 46.55 | Upgrade |
EBT Excluding Unusual Items | 2,414 | 2,369 | 2,170 | 1,797 | 1,501 | 1,128 | Upgrade |
Gain (Loss) on Sale of Investments | 43.68 | 43.68 | - | - | - | - | Upgrade |
Pretax Income | 2,457 | 2,413 | 2,170 | 1,797 | 1,501 | 1,128 | Upgrade |
Income Tax Expense | 38.46 | 42.9 | 68.52 | 107.71 | 114.07 | 92.79 | Upgrade |
Earnings From Continuing Operations | 2,419 | 2,370 | 2,101 | 1,689 | 1,387 | 1,035 | Upgrade |
Minority Interest in Earnings | -61.52 | -54.67 | -55.46 | -38.2 | -10.66 | 20.47 | Upgrade |
Net Income | 2,357 | 2,315 | 2,046 | 1,651 | 1,377 | 1,055 | Upgrade |
Net Income to Common | 2,357 | 2,315 | 2,046 | 1,651 | 1,377 | 1,055 | Upgrade |
Net Income Growth | 8.35% | 13.16% | 23.95% | 19.91% | 30.43% | 21.29% | Upgrade |
Shares Outstanding (Basic) | 350 | 350 | 350 | 350 | 350 | 350 | Upgrade |
Shares Outstanding (Diluted) | 350 | 350 | 350 | 350 | 350 | 350 | Upgrade |
EPS (Basic) | 6.74 | 6.62 | 5.85 | 4.72 | 3.93 | 3.02 | Upgrade |
EPS (Diluted) | 6.74 | 6.62 | 5.85 | 4.72 | 3.93 | 3.02 | Upgrade |
EPS Growth | 8.35% | 13.16% | 23.95% | 19.91% | 30.43% | 21.29% | Upgrade |
Free Cash Flow | -270.53 | -858.19 | -252.74 | 1,330 | 929.27 | 1,420 | Upgrade |
Free Cash Flow Per Share | -0.77 | -2.45 | -0.72 | 3.80 | 2.65 | 4.06 | Upgrade |
Dividend Per Share | 2.430 | 4.770 | 4.320 | 3.480 | 2.800 | 2.100 | Upgrade |
Dividend Growth | -47.85% | 10.42% | 24.14% | 24.29% | 33.33% | - | Upgrade |
Gross Margin | 32.17% | 33.30% | 34.22% | 32.88% | 31.95% | 31.61% | Upgrade |
Operating Margin | 19.92% | 21.04% | 22.04% | 20.46% | 20.22% | 19.02% | Upgrade |
Profit Margin | 18.64% | 20.67% | 21.52% | 19.86% | 18.99% | 18.01% | Upgrade |
Free Cash Flow Margin | -2.14% | -7.66% | -2.66% | 16.01% | 12.82% | 24.23% | Upgrade |
EBITDA | 3,015 | 2,711 | 2,358 | 1,960 | 1,728 | 1,378 | Upgrade |
EBITDA Margin | 23.84% | 24.20% | 24.80% | 23.59% | 23.84% | 23.51% | Upgrade |
D&A For EBITDA | 495.34 | 354.76 | 262.57 | 259.77 | 262.11 | 263.23 | Upgrade |
EBIT | 2,519 | 2,356 | 2,096 | 1,700 | 1,466 | 1,115 | Upgrade |
EBIT Margin | 19.92% | 21.04% | 22.04% | 20.46% | 20.22% | 19.02% | Upgrade |
Effective Tax Rate | 1.57% | 1.78% | 3.16% | 6.00% | 7.60% | 8.23% | Upgrade |
Advertising Expenses | - | 42.05 | 35.72 | 32.82 | 22.79 | 17.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.